Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587938 · ClinicalTrials.gov registry record
BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 200
- Enrollment target
NCT00587938: Completed study, sponsored by Mayo Clinic.
NCT00587938 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587938 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Measurement of brain natriuretic peptide (BNP) in dyspneic patients increases diagnostic accuracy for congestive heart failure (CHF). Limited information is available regarding economic outcomes attributable to BNP assay. The aim of this study was to assess the economic impact of BNP assay in elderly dyspneic patients presenting to the emergency department (ED).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-03 |
What the finished NCT00587938 record still lists
NCT00587938 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00587938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00587938 about?
NCT00587938 is a clinical study titled "BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED". Measurement of brain natriuretic peptide (BNP) in dyspneic patients increases diagnostic accuracy for congestive heart failure (CHF). Limited information is available regarding economic outcomes attributable to BNP assay. The aim of this study was to assess the economic impact of BNP assay in elderl...
What is the current status of trial NCT00587938?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2003-12. Estimated completion is 2005-03.
Who is sponsoring clinical trial NCT00587938?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia